These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28826666)

  • 41. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.
    El Khoury P; Plengpanich W; Frisdal E; Le Goff W; Khovidhunkit W; Guerin M
    Atherosclerosis; 2014 May; 234(1):193-9. PubMed ID: 24674903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Higher level of plasma cholesteryl ester transfer activity from high-density lipoprotein to apo B-containing lipoproteins in subjects with angiographically detectable coronary artery disease.
    Hibino T; Sakuma N; Sato T
    Clin Cardiol; 1996 Jun; 19(6):483-6. PubMed ID: 8790953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.
    Okada T; Ohama T; Okazaki M; Kanno K; Matsuda H; Sairyo M; Zhu Y; Saga A; Kobayashi T; Masuda D; Koseki M; Nishida M; Sakata Y; Yamashita S
    PLoS One; 2018; 13(1):e0190875. PubMed ID: 29304079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
    Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
    J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
    Kennedy AL; Wasan KM
    J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
    Di Giorgi N; Michelucci E; Smit JM; Scholte AJHA; El Mahdiui M; Knuuti J; Buechel RR; Teresinska A; Pizzi MN; Roque A; Poddighe R; Parodi O; Pelosi G; Caselli C; Neglia D; Rocchiccioli S
    Atherosclerosis; 2021 Dec; 339():1-11. PubMed ID: 34801858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel liquid chromatography-mass spectrometrymethod to analyze hdl lipidome.
    Patol Fiziol Eksp Ter; 2016; 60(3):95-100. PubMed ID: 29244914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
    Sutter I; Klingenberg R; Othman A; Rohrer L; Landmesser U; Heg D; Rodondi N; Mach F; Windecker S; Matter CM; Lüscher TF; von Eckardstein A; Hornemann T
    Atherosclerosis; 2016 Mar; 246():130-40. PubMed ID: 26773473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed increase in high density lipoprotein-phospholipids after ingestion of a fat load in normolipidemic patients with coronary artery disease.
    Groener JE; Scheek LM; van Ramshorst E; Krauss XH; van Tol A
    Atherosclerosis; 1998 Apr; 137(2):311-9. PubMed ID: 9622274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans.
    Park KW; Choi JH; Kim HK; Oh S; Chae IH; Kim HS; Oh BH; Lee MM; Park YB; Choi YS
    Clin Genet; 2003 Jan; 63(1):31-8. PubMed ID: 12519369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency.
    Zakiev E; Rached F; Lhomme M; Darabi-Amin M; Ponnaiah M; Becker PH; Therond P; Serrano CV; Santos RD; Chapman MJ; Orekhov A; Kontush A
    J Clin Lipidol; 2019; 13(3):468-480.e8. PubMed ID: 31003938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
    Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease.
    Suzuki M; Wada H; Maeda S; Saito K; Minatoguchi S; Saito K; Seishima M
    Clin Chem; 2005 Jan; 51(1):132-7. PubMed ID: 15550473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D; İlhan N; İlhan N; Akbulut M
    Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.